Crossmark

Peripheral blood biomarkers correlate with outcomes in advanced non-small cell lung Cancer patients treated with anti-PD-1 antibodies

Crossref DOI link: https://doi.org/10.1186/s40425-018-0447-2

Published Online: 2018-11-23

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Soyano, Aixa E.

Dholaria, Bhagirathbhai

Marin-Acevedo, Julian A.

Diehl, Nancy

Hodge, David

Luo, Yan

Manochakian, Rami

Chumsri, Saranya

Adjei, Alex

Knutson, Keith L.

Lou, Yanyan
License Information

Text and Data Mining valid from 2018-11-23
More Information

Article History

Received: 9 July 2018

Accepted: 8 November 2018

First Online: 23 November 2018

Ethics approval and consent to participate

: Our study was approved by the Mayo Clinic Institutional Review Board. The study was conducted in accordance with the declaration of Helsinki.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.